Literature DB >> 8876240

Regulation of striatal D1A dopamine receptor gene transcription by Brn-4.

H Okazawa1, I Imafuku, M T Minowa, I Kanazawa, H Hamada, M M Mouradian.   

Abstract

Brn-4 is a member of the POU transcription factor family and is expressed in the central nervous system. In this study, we addressed whether Brn-4 regulates expression of the D1A dopamine receptor gene. We found a functional Brn-4 responsive element in the intron of this gene by means of cotransfection chloramphenical acetyltransferase assays. This region contains two consensus sequences for binding of POU factors. Gel mobility-shift assays using glutathione S-transferase-Brn-4 fusion protein indicated that Brn-4 binds to these sequences. Both these sites are essential for transactivation by Brn-4 because deletion of either significantly reduced this enhancer activity. In situ hybridization revealed colocalization of Brn-4 and D1A mRNAs at the level of a single neuron in the rat striatum where this dopamine receptor is most abundantly expressed. Gel mobility-supershift assay using rat striatal nuclear extract and Brn-4 antibody confirmed the presence of Brn-4 in this brain region and its ability to bind to its consensus sequences in the D1A gene. These data suggest a functional role for Brn-4 in the expression of the D1A dopamine receptor gene both in vitro and in vivo.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8876240      PMCID: PMC38161          DOI: 10.1073/pnas.93.21.11933

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  47 in total

1.  Characterization of gene organization and promoter region of the rat dopamine D1 receptor gene.

Authors:  Q Y Zhou; C Li; O Civelli
Journal:  J Neurochem       Date:  1992-11       Impact factor: 5.372

2.  Physical fine mapping of genes underlying X-linked deafness and non fra (X)-X-linked mental retardation at Xq21.

Authors:  I Bach; D Robinson; N Thomas; H H Ropers; F P Cremers
Journal:  Hum Genet       Date:  1992-08       Impact factor: 4.132

3.  Biochemical characterization of the Oct-2 POU domain with implications for bipartite DNA recognition.

Authors:  M C Botfield; A Jancso; M A Weiss
Journal:  Biochemistry       Date:  1992-06-30       Impact factor: 3.162

4.  Synergistic activation of the rat growth hormone promoter by Pit-1 and the thyroid hormone receptor.

Authors:  F Schaufele; B L West; J D Baxter
Journal:  Mol Endocrinol       Date:  1992-04

5.  The Juberg-Marsidi syndrome maps to the proximal long arm of the X chromosome (Xq12-q21).

Authors:  P Saugier-Veber; V Abadie; A Moncla; M Mathieu; C Piussan; C Turleau; J F Mattei; A Munnich; S Lyonnet
Journal:  Am J Hum Genet       Date:  1993-06       Impact factor: 11.025

6.  Cretinism with combined hormone deficiency caused by a mutation in the PIT1 gene.

Authors:  K Tatsumi; K Miyai; T Notomi; K Kaibe; N Amino; Y Mizuno; H Kohno
Journal:  Nat Genet       Date:  1992-04       Impact factor: 38.330

7.  Mutation of the POU-specific domain of Pit-1 and hypopituitarism without pituitary hypoplasia.

Authors:  R W Pfäffle; G E DiMattia; J S Parks; M R Brown; J M Wit; M Jansen; H Van der Nat; J L Van den Brande; M G Rosenfeld; H A Ingraham
Journal:  Science       Date:  1992-08-21       Impact factor: 47.728

8.  A mutation in the POU-homeodomain of Pit-1 responsible for combined pituitary hormone deficiency.

Authors:  S Radovick; M Nations; Y Du; L A Berg; B D Weintraub; F E Wondisford
Journal:  Science       Date:  1992-08-21       Impact factor: 47.728

9.  The DNA binding specificity of the bipartite POU domain and its subdomains.

Authors:  C P Verrijzer; M J Alkema; W W van Weperen; H C Van Leeuwen; M J Strating; P C van der Vliet
Journal:  EMBO J       Date:  1992-12       Impact factor: 11.598

10.  Down-regulation of the POU transcription factor SCIP is an early event in oligodendrocyte differentiation in vitro.

Authors:  E J Collarini; R Kuhn; C J Marshall; E S Monuki; G Lemke; W D Richardson
Journal:  Development       Date:  1992-09       Impact factor: 6.868

View more
  6 in total

1.  Gbx2 directly restricts Otx2 expression to forebrain and midbrain, competing with class III POU factors.

Authors:  Fumitaka Inoue; Daisuke Kurokawa; Maiko Takahashi; Shinichi Aizawa
Journal:  Mol Cell Biol       Date:  2012-05-07       Impact factor: 4.272

2.  POU domain transcription factor brain 4 confers pancreatic alpha-cell-specific expression of the proglucagon gene through interaction with a novel proximal promoter G1 element.

Authors:  M A Hussain; J Lee; C P Miller; J F Habener
Journal:  Mol Cell Biol       Date:  1997-12       Impact factor: 4.272

Review 3.  POU domain transcription factors in embryonic development.

Authors:  G J Veenstra; P C van der Vliet; O H Destrée
Journal:  Mol Biol Rep       Date:  1997-08       Impact factor: 2.316

4.  Otic mesenchyme cells regulate spiral ganglion axon fasciculation through a Pou3f4/EphA4 signaling pathway.

Authors:  Thomas M Coate; Steven Raft; Xiumei Zhao; Aimee K Ryan; E Bryan Crenshaw; Matthew W Kelley
Journal:  Neuron       Date:  2012-01-12       Impact factor: 17.173

5.  Dopamine receptor regulating factor, DRRF: a zinc finger transcription factor.

Authors:  C K Hwang; U M D'Souza; A J Eisch; S Yajima; C H Lammers; Y Yang; S H Lee; Y M Kim; E J Nestler; M M Mouradian
Journal:  Proc Natl Acad Sci U S A       Date:  2001-06-05       Impact factor: 11.205

6.  Pou3f4-mediated regulation of ephrin-b2 controls temporal bone development in the mouse.

Authors:  Steven Raft; Thomas M Coate; Matthew W Kelley; E Bryan Crenshaw; Doris K Wu
Journal:  PLoS One       Date:  2014-10-09       Impact factor: 3.240

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.